Joanne S. Haviland

Joanne S. Haviland

London, ENG, United Kingdom

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 75 publications

Hypofractionated nodal radiotherapy in breast cancer: time for an updated standard of care?

Hypofractionated nodal radiotherapy in breast cancer: time for an updated standard of care?

Journal: Lancet (London, England)

Published: January 06, 2026

Hypofractionated breast radiotherapy for 1 week versus 3 weeks (FAST-Forward): 10-year efficacy and late normal tissue effects from a multicentre, open-label, non-inferiority, phase 3, randomised controlled trial and 5-year efficacy results from a randomised axillary substudy.

Hypofractionated breast radiotherapy for 1 week versus 3 weeks (FAST-Forward): 10-year efficacy and late normal tissue effects from a multicentre, open-label, non-inferiority, phase 3, randomised controlled trial and 5-year efficacy results from a randomised axillary substudy.

Journal: The Lancet. Oncology

Published: November 14, 2025

Clinical efficacy of subsensory sacral neuromodulation in adults with faecal incontinence: The SUBSoNIC crossover randomised controlled trial and cohort follow-up study.

Clinical efficacy of subsensory sacral neuromodulation in adults with faecal incontinence: The SUBSoNIC crossover randomised controlled trial and cohort follow-up study.

Journal: Colorectal disease : the official journal of the Association of Coloproctology of Great Britain and Ireland

Published: July 31, 2025

Genomic and spatial analysis of local recurrences following risk-adapted breast radiotherapy in the IMPORT trials.

Genomic and spatial analysis of local recurrences following risk-adapted breast radiotherapy in the IMPORT trials.

Journal: Breast cancer research : BCR

Published: July 11, 2025

Five-year trends and baseline predictors of patient-reported adverse events following breast radiotherapy with a boost in the IMPORT HIGH phase III randomised controlled trial.

Five-year trends and baseline predictors of patient-reported adverse events following breast radiotherapy with a boost in the IMPORT HIGH phase III randomised controlled trial.

Journal: Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology

Published: May 16, 2025

Patient and public involvement in the SPRUCE methodology study investigating electronic patient reported outcomes in oncology clinical trials.

Patient and public involvement in the SPRUCE methodology study investigating electronic patient reported outcomes in oncology clinical trials.

Journal: Research involvement and engagement

Published: February 13, 2025

Patient- and clinician-assessed five-year normal tissue effects following one-week versus three-week axillary radiotherapy for breast cancer: Results from the phase III FAST-Forward trial randomised nodal sub-study.

Patient- and clinician-assessed five-year normal tissue effects following one-week versus three-week axillary radiotherapy for breast cancer: Results from the phase III FAST-Forward trial randomised nodal sub-study.

Journal: Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology

Published: February 09, 2025

Partial-breast radiotherapy after breast conservation surgery for women with early breast cancer (UK IMPORT LOW): 10-year outcomes from a multicentre, open-label, randomised, controlled, phase 3, non-inferiority trial.

Partial-breast radiotherapy after breast conservation surgery for women with early breast cancer (UK IMPORT LOW): 10-year outcomes from a multicentre, open-label, randomised, controlled, phase 3, non-inferiority trial.

Journal: The Lancet. Oncology

Published: January 31, 2025

Platform trials-an emerging methodology for perioperative medicine: a narrative review.

Platform trials-an emerging methodology for perioperative medicine: a narrative review.

Journal: Perioperative medicine (London, England)

Published: December 23, 2024

Regional Lymph Node Delineation variability and its Dosimetric Impact in Breast Cancer Radiotherapy.

Regional Lymph Node Delineation variability and its Dosimetric Impact in Breast Cancer Radiotherapy.

Journal: Clinical oncology (Royal College of Radiologists (Great Britain))

Published: November 11, 2024

Radiation-induced lymphocyte apoptosis and chromosomic aberrations for prediction of toxicities in patients undergoing radical radiotherapy for breast or prostate cancers.

Radiation-induced lymphocyte apoptosis and chromosomic aberrations for prediction of toxicities in patients undergoing radical radiotherapy for breast or prostate cancers.

Journal: The British journal of radiology

Published: July 28, 2024

Perspectives of People With HIV on Implementing Long-acting Cabotegravir Plus Rilpivirine in Clinics and Community Settings in the United Kingdom: Results From the Antisexist, Antiracist, Antiageist Implementing Long-acting Novel Antiretrovirals Study.

Perspectives of People With HIV on Implementing Long-acting Cabotegravir Plus Rilpivirine in Clinics and Community Settings in the United Kingdom: Results From the Antisexist, Antiracist, Antiageist Implementing Long-acting Novel Antiretrovirals Study.

Journal: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America

Published: July 15, 2024

Showing 1-12 of 75

Last Updated: 09/26/2026